Big Pharma: Gaming the system
The New Statesman | UK politics and culture
Pharmaceutical Sales Shifts and NICE's Role
This chapter examines the evolving sales strategies of pharmaceutical companies, particularly their pivot towards influencing the National Institute for Health and Care Excellence (NICE) for drug approvals. It highlights the challenges of ensuring safe medication access while managing the industry's profit motives and the potential risks of hastened drug rollouts.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
